Lisa has 20 years drug discovery research experience in oncology and neurodegeneration.  Prior to Epitopea, she was a Director of Drug Discovery at BenevolentAI and also spent more than 10 years with Mission Therapeutics, where she was a team leader responsible for developing screening capabilities to deliver drug candidates up to the pre-clinical stage. 

Before this, Lisa was a Senior Scientist at KuDOS Pharmaceuticals.  Lisa earned her PhD from the Northern Institute for Cancer Research at the University of Newcastle upon Tyne.